New oral disease-modifying therapies for multiple sclerosis

Several promising, oral disease-modifying therapies for multiple sclerosis are currently being evaluated in clinical trials. The arrival of effective oral agents for multiple sclerosis will be a major advance in the global effort to alter the natural history of this chronic disease.

Detalles Bibliográficos
Autores principales: Bagert, Bridget A, Bourdette, Dennis
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports Ltd 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924710/
https://www.ncbi.nlm.nih.gov/pubmed/20948746
http://dx.doi.org/10.3410/M1-34
_version_ 1782185620524761088
author Bagert, Bridget A
Bourdette, Dennis
author_facet Bagert, Bridget A
Bourdette, Dennis
author_sort Bagert, Bridget A
collection PubMed
description Several promising, oral disease-modifying therapies for multiple sclerosis are currently being evaluated in clinical trials. The arrival of effective oral agents for multiple sclerosis will be a major advance in the global effort to alter the natural history of this chronic disease.
format Text
id pubmed-2924710
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medicine Reports Ltd
record_format MEDLINE/PubMed
spelling pubmed-29247102010-10-14 New oral disease-modifying therapies for multiple sclerosis Bagert, Bridget A Bourdette, Dennis F1000 Med Rep Review Article Several promising, oral disease-modifying therapies for multiple sclerosis are currently being evaluated in clinical trials. The arrival of effective oral agents for multiple sclerosis will be a major advance in the global effort to alter the natural history of this chronic disease. Medicine Reports Ltd 2009-05-08 /pmc/articles/PMC2924710/ /pubmed/20948746 http://dx.doi.org/10.3410/M1-34 Text en © 2009 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Bagert, Bridget A
Bourdette, Dennis
New oral disease-modifying therapies for multiple sclerosis
title New oral disease-modifying therapies for multiple sclerosis
title_full New oral disease-modifying therapies for multiple sclerosis
title_fullStr New oral disease-modifying therapies for multiple sclerosis
title_full_unstemmed New oral disease-modifying therapies for multiple sclerosis
title_short New oral disease-modifying therapies for multiple sclerosis
title_sort new oral disease-modifying therapies for multiple sclerosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924710/
https://www.ncbi.nlm.nih.gov/pubmed/20948746
http://dx.doi.org/10.3410/M1-34
work_keys_str_mv AT bagertbridgeta neworaldiseasemodifyingtherapiesformultiplesclerosis
AT bourdettedennis neworaldiseasemodifyingtherapiesformultiplesclerosis

Ejemplares similares